STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Apr. 30, 2026 |
Apr. 30, 2025 |
Apr. 30, 2026 |
Apr. 30, 2025 |
|
| Stock compensation costs | $ 590,000 | $ 1,096,000 | $ 1,182,000 | $ 2,187,000 |
| Eight Investors [Member] | ||||
| Number of units sold | 7.4 | |||
| Aggregate purchase price | $ 1,850,000 | |||
| Number of common stock issued | 462,500 | |||
| Number of warrants purchased | 462,500 | |||
| Equity Option [Member] | ||||
| Stock compensation costs | 9,000 | 265,000 | $ 194,000 | 514,000 |
| Unamortized compensation costs | 57,000 | 57,000 | ||
| Warrant [Member] | ||||
| Stock compensation costs | 0 | $ 810,000 | 215,000 | $ 1,620,000 |
| Unamortized compensation costs | $ 1,122,000 | $ 1,122,000 | ||
| Warrants outstanding | 500,000 | 500,000 | ||
| Warrants description | The Warrants vest in five equal tranches of 100,000 shares, at various exercise prices ranging between $3.50 - $10.00 per share, and are exercisable based upon meeting certain conditions provided in the Consulting Agreement. Once vested, the Warrants are exercisable for a period of ninety (90) days from the date they become exercisable. The fair value of the warrants was determined to be $1,122,000. The Company will begin to amortize the $1,122,000 fair value when management estimates the vesting conditions are probable of being achieved. | |||
| Employees [Member] | ||||
| Option granted | 7,790 | |||
| Aggregate fair value | $ 20,000 | |||
| Options forfeited | 85,877 | |||
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of non-vested options forfeited. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|